MedTrace Logo

User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate).

NCT06526637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-27

No results posted yet for this study

Summary

The aim of this study is to evaluate the acceptability, safety and efficiency of the Palliate intervention.

The Palliate intervention is a nurse-led process that includes training and documentation materials to support lay carers in administering top up medications to loved ones at the end of life at home. The Palliate intervention was designed based on the CARiAD\* intervention using user testing and has been successfully piloted and rolled out in Central and North West London National Health Service (NHS) Foundation Trust.

\*CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients.

Conditions

  • End of Life
  • Support, Family

Interventions

OTHER

Paper Package

Paper based (as per current practice at Central and North West London (CNWL) NHS Foundation Trust) version of Palliate.

OTHER

V1 + Preparation Sheet

Paper based version of Palliate plus a preparation sheet, that provides visual cues as to what equipment is required for the preparation and administration of the medications.

OTHER

V2 + Video Training

Hybrid - paper based materials, preparation sheet, and video instructions available via an interactive portable document format (PDF) version of the training materials.

Sponsors & Collaborators

  • Oak Foundation

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Leila Shepherd, PhD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-26
Primary Completion
2025-11-01
Completion
2025-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526637 on ClinicalTrials.gov